Search results
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 1 day agoThe study failed to meet the primary endpoint of improvement in motor function, which was assessed...
Athlete of the Week: Ainsworth's Carter Nelson
KLKN Lincoln· 6 days agoAinsworth’s Carter Nelson has been a varsity regular since his freshman year. Nelson is a multi-sport athlete participating in football, basketball and...
Sarepta Therapeutics gains as Pfizer failure removes overhang
Investing.com· 3 days agoSarepta Therapeutics gains as Pfizer failure removes overhang
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 3 days agoThe primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment (NSAA) at one year after treatment.
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 3 days agoThe primary endpoint was the change from baseline in the North Star Ambulatory Assessment (NSAA)...
2024 NEMFCA 8-Man Hall of Fame Inductee Salutes - Curt Johnson, Lawrence High School
McCook Daily Gazette· 6 days agoCOACH CURT JOHNSON – LAWRENCE HIGH SCHOOL (Here is our 5th of twelve 2024 NEMFCA Hall of Fame inductees. Today we feature one of 8-Man football’s finest Coaches ever, the incomparable Coach Curt Johnson.)...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks· 3 days agoFree Report) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular dystrophy (“DMD”) failed to meet the primary endpoint ...
Athlete of the Year nominee: Erickson’s athleticism served him well at the Class B level in all...
York News-Times· 3 days agoNOTE: This is the eighth of 10 installments recognizing each of the five finalists for the York...